Clinical Trials Directory

Insulin Resistance Intervention After Stroke (IRIS) Trial

The purpose of this study is to determine if pioglitazone is effective in preventing future strokes or heart attacks among non-diabetic persons who have had a recent ischemic stroke.

Stanford is now accepting new patients for this trial. Please contact Madelleine Garcia at 6507252326 for more information.



  • drug : placebo
  • drug : pioglitazone

Phase: Phase 3


Ages Eligible For Study:

40 Years - N/A

External Links

Explore related trials

Contact information

Primary Contact:

Madelleine Garcia 6507252326

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: